Lista de obras - T Yau - Dominio Público Uruguay

11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective

artículo científico publicado en 2013

A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

artículo científico publicado en 2016

A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).

artículo científico publicado en 2007

A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.

artículo científico publicado en 2008

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2012

Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan.

artículo científico publicado en 2005

Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.

artículo científico publicado en 2014

Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour.

artículo científico publicado en 2013

Androgen deprivation therapy and cardiovascular risk in chinese patients with nonmetastatic carcinoma of prostate

artículo científico publicado en 2014

Breast and pelvic masses in a myeloma patient

scientific article published on 25 June 2008

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

artículo científico publicado en 2016

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer

artículo científico publicado en 2011

Common malignancies with uncommon sites of presentation: case 2. Mantle-cell lymphoma of the prostate.

artículo científico publicado en 2003

Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

artículo científico publicado en 2008

Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.

artículo científico publicado en 2014

Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?

artículo científico publicado en 2016

Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2007

Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study

artículo científico publicado en 2016

Family-Specific Training Improves Linear B Cell Epitope Prediction for Emerging Viruses

artículo científico publicado en 2023

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

artículo científico publicado en 2014

High-intensity focused ultrasound as a treatment for colorectal liver metastasis in difficult position ⬇️

artículo científico publicado el 13 de agosto de 2011

Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors

artículo científico publicado en 2009

Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.

artículo científico publicado en 2018

Hong Kong consensus recommendations on the management of hepatocellular carcinoma

artículo científico publicado en 2015

Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.

artículo científico publicado en 2017

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

artículo científico publicado en 2006

Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong

scientific article published on 20 June 2014

Integrating molecular mechanisms and clinical evidence in the management of trastuzumab resistant or refractory HER-2⁺ metastatic breast cancer.

artículo científico publicado en 2011

Intramuscular recurrence in a hepatocellular carcinoma patient with indolent disease course.

artículo científico publicado en 2008

Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy

artículo científico publicado en 2014

Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.

artículo científico publicado en 2014

Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.

artículo científico publicado en 2009

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.

artículo científico publicado en 2012

Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era.

artículo científico publicado en 2014

Massive rectal bleeding in a patient with a history of hepatocellular carcinoma

scientific article published on 01 October 2008

Metastatic Pancreatic Cancer: Are We Making Progress in Treatment? ⬇️

artículo científico publicado el 4 de diciembre de 2012

Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

artículo científico

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

artículo científico publicado en 2017

Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer

artículo científico publicado en 2015

Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases

artículo científico publicado en 2012

PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success.

artículo científico publicado en 2009

Pembrolizumab (Keytruda)

artículo científico publicado en 2016

Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.

artículo científico publicado en 2010

Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.

artículo científico publicado en 2009

Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics

artículo científico publicado en 2011

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease ⬇️

artículo científico publicado el 9 de marzo de 2012

Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer

artículo científico publicado en 2015

Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma

artículo científico publicado en 2015

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.

artículo científico publicado en 2015

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2015

Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.

artículo científico publicado en 2010

Prognostic significance of CD26 in patients with colorectal cancer

artículo científico publicado en 2014

Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma.

artículo científico publicado en 2015

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2015

Retrospective study of metachronous lung metastases from primary hepatocellular carcinoma

artículo científico publicado en 2014

Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.

artículo científico publicado en 2008

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.

artículo científico publicado en 2018

Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.

artículo científico publicado en 2013

Surveillance in stage I seminoma patients: a long-term assessment.

artículo científico publicado en 2009

Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma

artículo científico publicado en 2012

Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas

artículo científico publicado en 2014

Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma.

artículo científico publicado en 2014

Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?

artículo científico publicado en 2012

The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance

artículo científico publicado en 2013

The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong.

artículo científico publicado en 2016

The clinicopathological significance of miR-133a in colorectal cancer

artículo científico publicado en 2014

The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?

artículo científico publicado en 2012

The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong Kong.

artículo científico publicado en 2016

The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib

artículo científico publicado en 2011

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits

artículo científico publicado en 2012

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma

artículo científico publicado en 2012

Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.

artículo científico publicado en 2014

Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease

artículo científico publicado en 2010

Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy

artículo científico publicado en 2008

What determines treatment success and future perspectives?

artículo científico publicado en 2016

Lista de obras de T Yau

11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective

A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).

A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.

Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan.

Advanced pancreatic cancer: flourishing novel approaches in the era of biological therapy.

Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour.

Androgen deprivation therapy and cardiovascular risk in chinese patients with nonmetastatic carcinoma of prostate

Breast and pelvic masses in a myeloma patient

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer

Common malignancies with uncommon sites of presentation: case 2. Mantle-cell lymphoma of the prostate.

Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.

Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?

Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma.

Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study

Family-Specific Training Improves Linear B Cell Epitope Prediction for Emerging Viruses

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

High-intensity focused ultrasound as a treatment for colorectal liver metastasis in difficult position ⬇️

Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors

Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.

Hong Kong consensus recommendations on the management of hepatocellular carcinoma

Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

Initial experience with the Oncotype DX assay in decision-making for adjuvant therapy of early oestrogen receptor-positive breast cancer in Hong Kong

Integrating molecular mechanisms and clinical evidence in the management of trastuzumab resistant or refractory HER-2⁺ metastatic breast cancer.

Intramuscular recurrence in a hepatocellular carcinoma patient with indolent disease course.

Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy

Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.

Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012.

Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era.

Massive rectal bleeding in a patient with a history of hepatocellular carcinoma

Metastatic Pancreatic Cancer: Are We Making Progress in Treatment? ⬇️

Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer

Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases

PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success.

Pembrolizumab (Keytruda)

Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.

Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.

Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics

Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease ⬇️

Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer

Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.

Prognostic significance of CD26 in patients with colorectal cancer

Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma.

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

Retrospective study of metachronous lung metastases from primary hepatocellular carcinoma

Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.

Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.

Surveillance in stage I seminoma patients: a long-term assessment.

Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma

Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas

Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma.

Targeted therapy in the management of advanced gastric cancer: are we making progress in the era of personalized medicine?

The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance

The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong.

The clinicopathological significance of miR-133a in colorectal cancer

The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?

The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong Kong.

The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma

Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.

Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease

Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy

What determines treatment success and future perspectives?